atovaquone has been researched along with Malaria in 147 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.36) | 18.7374 |
1990's | 11 (7.48) | 18.2507 |
2000's | 46 (31.29) | 29.6817 |
2010's | 72 (48.98) | 24.3611 |
2020's | 16 (10.88) | 2.80 |
Authors | Studies |
---|---|
Alzeer, J; Chollet, J; Heinze-Krauss, I; Hubschwerlen, C; Matile, H; Ridley, RG | 1 |
Batchelor, JF; Bueno, JM; Capon, EC; Cheesman, NJ; Chicharro, J; Fernández, E; Fiandor, JM; Fry, M; Gargallo-Viola, D; Gómez de las Heras, F; Herreros, E; Hudson, AT; León, ML; Pudney, M; Trimming, H; Woolven, J; Yeates, CL | 1 |
Beck, HP; Brun, R; Cohen, SB; Dartois, V; Dharia, NV; Diagana, TT; Fidock, DA; Goh, A; González-Páez, GE; Jegla, T; Keller, TH; Lakshminarayana, SB; Lee, MC; McNamara, C; Nosten, F; Plouffe, DM; Renia, L; Rottmann, M; Russell, B; Schmitt, EK; Seitz, P; Spencer, KR; Suwanarusk, R; Tan, J; Winzeler, EA; Yeung, BK; Zou, B | 1 |
Bathurst, I; Buckner, FS; Burrows, J; Charman, SA; Charman, WN; Creason, S; Deng, X; El Mazouni, F; Floyd, DM; Gujjar, R; Matthews, D; Phillips, MA; Rathod, PK; Shackleford, DM; White, J; White, KL | 1 |
Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Rodrigues, T | 1 |
Amewu, R; Berger, O; Berry, NG; Biagini, GA; Charoensutthivarakul, S; Fisher, NE; Gibbons, P; Hill, A; Hong, WD; Leung, SC; Mbekeani, A; Nixon, GL; O'Neill, PM; Pacorel, B; Pidathala, C; Sharma, R; Shone, AE; Srivastava, A; Stocks, PA; Taylor, L; Ward, SA; Warman, AJ | 2 |
Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
Bronze, MR; da Cruz, FP; Gamo, FJ; Gonçalves, D; Gut, J; Lafuente-Monasterio, MJ; Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Ressurreição, AS; Rodrigues, T; Rosenthal, PJ; Schneider, G; Sitoe, AR | 1 |
Albuquerque, IS; Bronze, MR; Gonçalves, LM; Guedes, RC; Gut, J; Lopes, F; Meireles, P; Moreira, R; O'Neill, PM; Oliveira, R; Pires, E; Prudêncio, M; Rosenthal, PJ | 1 |
Achar, V; Angulo-Barturen, I; Avery, VM; Awasthy, D; Bharath, S; Coburn-Flynn, O; Duffy, S; Ferrer, S; Fidock, DA; Gamo, FJ; Hameed P, S; Hosagrahara, V; Iyer, PS; Jiménez-Díaz, MB; Kavanagh, S; Lee, MC; Martínez, MS; Menasinakai, S; Morayya, S; Nanduri, R; Narayanan, S; Panduga, V; Prabhakar, KR; Raichurkar, A; Ramachandran, S; Rautela, N; Reddy, J; Sambandamurthy, VK; Sanz, LM; Saralaya, R; Shanbhag, G; Srivastava, A; Waterson, D | 1 |
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
Angulo-Barturen, Í; Bahamontes-Rosa, N; Ballell-Pages, L; Berry, NG; Biagini, GA; Blackman, MJ; Calderón, F; Castañeda, P; Crespo, B; de Cózar, C; de Mercado, J; Fernández, J; Frigerio, M; Guijarro, L; Jiménez-Díaz, MB; Martínez-Martínez, MS; McConville, M; Nixon, GL; O'Neill, PM; Santos-Villarejo, Á; Sanz, LM; Ward, SA; Washbourn, G | 1 |
Coelho, L; Lukens, AK; Mazitschek, R; Moreira, R; Nogueira, F; Paulo, A; Santos, SA; Wirth, DF | 1 |
Calderón, F; Fernández-Álvaro, E; Hong, WD; Nixon, GL; O'Neill, PM | 1 |
Barnard, L; Birkholtz, LM; Botha, M; Brunschwig, C; Burrows, JN; Chibale, K; Churchyard, A; Coetzer, TL; Denti, P; Egan, TJ; Laing, L; Lauterbach, S; Machado, M; Ndubi, F; Njogu, PM; Njoroge, M; Nondaba, S; Okombo, J; Prudêncio, M; Reader, J; Singh, K; Wiesner, L; Wilkinson, C; Wittlin, S; Yeates, C | 1 |
Berry, P; Campo, B; Cao, J; Ciaravino, V; Easom, EE; Erve, JCL; Freund, YR; Gamo, FJ; Guo, D; Jacobs, RT; Plattner, JJ; Rosenthal, PJ; Sanz, LM; Zhang, YK | 1 |
Avery, VM; Buchholz, M; Delves, MJ; Duffy, S; Fischli, C; Held, J; Knaab, TC; Kuna, K; Kurz, T; Lehmann, U; Leven, M; Lungerich, B; Meister, S; Meitzner, D; Mordmüller, B; Stahlke, P; Winzeler, EA; Wittlin, S | 1 |
Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Cheong, SL; Ng, CH; Tibon, NS | 1 |
Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y | 1 |
Abdel-Daim, MM; Alkhoudary, MS; Alsharif, KF; El-Sayed, SAE; Igarashi, I; Rizk, MA | 1 |
Adams, KL; Bopp, S; Catteruccia, F; Dabiré, RK; Diabaté, A; Hien, DFS; Lefèvre, T; Ma, E; Paré, PSL; Paton, DG; Probst, AS; Shaw, WR; Singh, N; Volkman, SK; Wirth, DF; Yerbanga, RS | 1 |
Boelle, PY; Jauréguiberry, S; Kendjo, E; Le Goff, M; Piarroux, R; Thellier, M | 1 |
Ahiya, AI; Lamb, IM; Lindner, SE; Mather, MW; Mell, JC; Morrisey, J; Rios, KT; Shukla, A; Vaidya, AB | 1 |
Baghdadi, HB; El-Sayed, SAE; Eltaysh, R; Igarashi, I; Rizk, MA | 1 |
Addo, M; Heitkamp, C; Jochum, J; Kreuels, B; Krumkamp, R; Landsmann, L; Moehlmann, MW; Radt, C; Ramharter, M; Reinsberg, F; Rothe, C; Vinnemeier, C | 1 |
Arun Kumar, K; Bhattacharyya, MK; Bhattacharyya, S; Dey, S; Fangaria, N; Padhi, S; Roy, A; Singh, P; Tabassum, W | 1 |
Bakshi, RP; Balta, VA; Canonizado, MA; Dziedzic, AG; Elahi, R; Jedlicka, AE; Mann, A; Mlambo, G; Nenortas, E; Owen, A; Prigge, ST; Romero-Rodriguez, K; Sayeed, A; Shapiro, TA; Sinnis, P; Stiffler, D; Sullivan, DJ; Tripathi, AK | 1 |
Arsuaga, M; Barreiro, P; de la Calle, F; de Miguel, R; Diaz, M; Loli-Ausejo, D; Tarin, EJ; Trigo, E | 1 |
Brett-Major, D; Fraser, J; Hickey, PW; Mitra, I; Riddle, MS; Tribble, DR | 1 |
Almeida, FG; Azevedo, MF; Buriticá, NL; Crispim, M; Katzin, AM; Kimura, EA; Melo, HR; Sussmann, RAC; Verdaguer, IB; Zafra, CA | 1 |
Abla, N; Chalon, S; Chughlay, MF; Haouala, A; Hutter, B; Lorch, U; Macintyre, F; Marie Tchouatieu, A | 1 |
Angarano, G; Castelli, F; Dell'Acqua, R; Di Gennaro, F; Fabrizio, C; L'Episcopia, M; Lo Caputo, S; Menegon, M; Monno, L; Saracino, A; Severini, C | 1 |
Akkouche, W; Barzon, L; Biasolo, MA; De Canale, E; Marini, G; Masiero, S; Menegotto, N; Palù, G; Sgarabotto, D | 1 |
Alagusundaramoorthy, SS; Jacob, A; Selvarajan, D; Sundaravel, S | 1 |
Arguin, PM; Mace, KE; Minta, AA; Tan, KR | 1 |
Darade, A; Pathak, S; Patravale, V; Sharma, S | 1 |
Hai, F; Islam, S | 1 |
Bakshi, RP; Ippolito, MM; Mlambo, G; Nenortas, E; Owen, A; Rannard, SP; Savage, AC; Shapiro, TA; Tatham, LM; Tripathi, AK | 1 |
Crum-Cianflone, NF; Edwards, R; Khattar, R | 1 |
Arsuaga, M; Dinkessa, AW; González, LM; Gray, J; Montero, E; Padial, ES; Puente, S; Sevilla, E; Trigo, E | 1 |
Furuya-Kanamori, L; Lau, CL; Mills, DJ; Mills, LC; Ramsey, L | 1 |
Meltzer, E; Schwartz, E | 1 |
Gutman, JR; Mayer, RC; Tan, KR | 1 |
Biber, A; Harel, R; Schwartz, E | 1 |
Gerstenlauer, C | 1 |
Cowell, AN; Winzeler, EA | 1 |
Garrido Jareño, M; Otero Reigada, MDC; Peman García, J; Ramírez Cuentas, JH; Roselló Guijarro, M; Urtasun Erburu, A | 1 |
Baier, M; Eisermann, P; Hagel, S; Reuken, PA; Rödel, J; Stallmach, A | 1 |
Angulo-Barturen, I; Avery, VM; Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Delves, MJ; Duffy, S; Ferrer, S; Forquer, IP; Gamo, FJ; Guy, RK; Herreros, E; Jiménez-Díaz, MB; Kelly, JX; Kocken, CHM; Kyle, DE; LaCrue, AN; Li, Y; Manetsch, R; Marfurt, J; Mather, MW; Morrisey, JM; Mutka, T; Nilsen, A; Noviyanti, R; Price, RN; Riscoe, MK; Ryan, E; Saenz, FE; Sanz, LM; Sebayang, BF; Shackleford, DM; Siegl, P; Sinden, RE; Steuten, J; Vaidya, AB; White, KL; Winter, RW; Wirjanata, G; Zeeman, AM | 1 |
Kain, KC | 2 |
Dickins, M; Gutteridge, W; Pudney, M; Woolley, JL; Zeman, A | 1 |
Beerahee, M | 1 |
Heisler, MH; Oyediran, AB | 1 |
Blagborough, AM; Churcher, TS; Gething, PW; Ghani, AC; Sinden, RE; Upton, LM | 1 |
Alemayehu, S; Coggeshall, P; Cohen, R; Feghali, K; Hang, J; Kamau, E; Komisar, J; Weina, PJ; Zapor, M | 1 |
Borhade, V; Pathak, S; Patravale, V; Sharma, S | 1 |
Ehrhardt, J; Frank, M; Kremsner, P; Trein, A | 1 |
Burchard, GD | 2 |
Amelot, A; Dupouy-Camet, J; Jeanmougin, M | 1 |
Berman, J; DiTusa, C; Gettayacamin, M; Im-erbsin, R; Kozar, MP; Ohrt, C; Pybus, B; Sousa, J; Tungtaeng, A | 1 |
Arguin, PM; Landman, KZ; Tan, KR | 1 |
Andrews, KT; Beattie, KD; Blundell, S; Campbell, A; Charman, SA; Coster, MJ; Davis, RA; Edstein, MD; Healy, PC; Koltun, M; MacKenzie, D; Pouwer, RH; Quinn, RJ; Schwartz, BD; Skinner-Adams, TS | 1 |
Bhardwaj, J; Goyal, M; Prakash, K; Puri, SK; Siddiqui, AJ; Soni, A; Tiwari, V | 1 |
Hoepelman, AI; Marzuki, S; Nuralitha, S; Roelands, J; Siregar, JE; Syafruddin, D; Verhoef, J | 1 |
Borhade, V; Deshpande, V; Gokarna, V; Kate, L; Pathak, S; Patravale, V; Prabhu, P; Sharma, S | 1 |
Cozijnsen, A; Goodman, CD; Jacobs-Lorena, M; Kita, K; Marzuki, S; Matsuoka, H; Matsuzaki, M; McFadden, GI; Mollard, V; Siregar, JE; Sturm, A; Syafruddin, D; Toyama, T; Vega-Rodríguez, J | 1 |
Howlett-Shipley, R; Quantick, O; Ross, D; Roughton, S | 1 |
Bar-Meir, M; Eisenberg, N; Lachish, T; Schwartz, E | 1 |
Shanks, D | 1 |
Buchanan, HD; Goodman, CD; McFadden, GI | 1 |
Hoepelman, AIM; Marzuki, S; Murdiyarso, LS; Nuralitha, S; Roelands, J; Siregar, JE; Syafruddin, D; Verhoef, J | 1 |
Andersson, H; Askling, HH; Falck, B; Rombo, L | 1 |
Covian, R; Gribble, GW; Hughes, LM; Trumpower, BL | 1 |
Afonso, A; Alves, AC; Castro, H; Lopes, D; Neto, Z; Rosário, VD; Tomás, AM | 1 |
Balu, L; Chevret, L; Habes, D; Orostegui, L; Pussard, E | 1 |
Hyde, JE; Müller, IB | 1 |
Hviid, A; Pasternak, B | 1 |
Bellagamba, R; D'Avolio, A; Gallo, AL; Ivanovic, J; Narciso, P; Nicastri, E; Pucillo, LP; Tempestilli, M; Tommasi, C | 1 |
Ensom, MH; Wilby, KJ | 1 |
Bozzo, P; Einarson, A; Irvine, MH | 1 |
Arguin, PM; Magill, AJ; Steinhardt, LC | 1 |
Buchholz, K; da Cruz, FP; Gamo, FJ; Hannus, M; Lafuente-Monasterio, MJ; Marti, M; Martin, C; Moreira, R; Mota, MM; Prudêncio, M; Rodrigues, T; Sönnichsen, B | 1 |
Fadden, SJ; Keene, DD; Roughton, S; Tong, JL | 1 |
Petersen, E; Schlagenhauf, P | 1 |
Bartoloni, A; Beltrame, A; Bouchaud, O; Calleri, G; Clerinx, J; Gautret, P; Grobusch, MP; Jelinek, T; Kaiser, A; Kern, P; Kremsner, PG; Matteelli, A; Méchaï, F; Mühlberger, N; Parola, P; Peyerl-Hoffmann, G; Probst, M; Schmid, ML; Weinke, T | 1 |
Amano, K; Ide, D; Kato, T; Okuda, J; Takei, Y; Yamaguchi, Y | 1 |
Dzinjalamala, FK; Laufer, MK; Laurens, MB; Masonga, R; Nyirenda, OM; Plowe, CV; Stokes-Riner, A; Taylor, TE; Thesing, PC | 1 |
Basco, LK; Delmont, J; Moyou-Somo, R; Ngane Foumane, V; Sayang, C; Soula, G; Tahar, R | 1 |
Chiodini, P; Evans, M; Morgan, GS | 1 |
Biagini, GA; Fisher, N; Lalloo, DG; Moss, DM; Nixon, GL; O'Neill, PM; Shone, AE; Ward, SA | 1 |
Jong, EC; Nothdurft, HD | 1 |
Ditters, JM; Ligthelm, RJ; Overbosch, D; Stricker, BH; Sturkenboom, MC; van Riemsdijk, MM | 1 |
Binder, R; Faucher, JF; Gruss, H; Kremsner, PG; Lell, B; Matsiegui, PB; Miller, GB; Missinou, MA; Neubauer, R; Que, JU | 1 |
Kager, PA | 1 |
Petersen, E | 1 |
Overbosch, D | 1 |
Tracey, C | 1 |
Fischer, PR; Stauffer, W | 1 |
Jomaa, H; Ortmann, R; Schlitzer, M; Wiesner, J | 1 |
Chambers, JA | 1 |
Jones, ME; Lessells, R; Welsby, PD | 1 |
Camus, D; De Boever, EH; Djossou, F; Dutoit, E; Hedgley, C; Høgh, B; Malvy, D; Miller, GB; Roskell, NS; Schilthuis, HJ | 1 |
Stingl, P | 1 |
Croft, AM | 4 |
Green, AD; Roberts, KI; Tuck, JJ | 1 |
Ha, KH; Hill, P; Kessl, JJ; Lange, BB; Merritt, AK; Meshnick, SR; Meunier, B; Trumpower, BL | 1 |
Beer, MD; Croft, AM; Herxheimer, A | 1 |
Kurtzhals, JA; Vestergaard, LS | 1 |
Kurtzhals, JA | 1 |
Berman, J; Duparc, S; Gutierrez, P; Luzz, M; Soto, J; Toledo, J | 1 |
Callen, EC; Church, CO | 1 |
Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
Le Bras, J; Loiseau, PM | 1 |
Hyde, JE | 1 |
Hunter, PR; Nakato, H; Vivancos, R | 1 |
Durrheim, DN; Massey, P; Speare, R | 1 |
D'Acremont, V; Genton, B; Landry, P; Senn, N | 1 |
Kita, K; Marzuki, S; Matsuoka, H; Siregar, JE; Syafruddin, D | 1 |
Berry, N; Biagini, GA; Bonar-Law, R; Bray, PG; Fisher, N; Meunier, B; O'Neill, PM; Owen, A; Stocks, PA; Ward, SA; Williams, DP | 1 |
Atlan, A; Gallien, S; Lagrange-Xelot, M; Molina, JM; Sarfati, C; Schlemmer, F; Taieb, F | 1 |
Christopherson, RI; Lyons, SD; Phillips, L; Rieckmann, KH; Seymour, KK | 1 |
Billingsley, PF; Fowler, RE; Pudney, M; Sinden, RE | 1 |
Alves, FP; Boulos, M; Cerutti, C; de Alencar, FE; Durlacher, RR; Milhous, W; Pang, LW | 1 |
Bloland, PB; Doumbo, OK; Kazembe, PN; Nwanyanwu, OC; Ruebush, TK; Watkins, WM | 1 |
Kremsner, PG; Lell, B; Luckner, D; Ndjavé, M; Scott, T | 1 |
Davis, TM | 1 |
Whitty, CJ | 1 |
Butcher, GA; Mendoza, J; Sinden, RE | 1 |
Croft, A; Geary, K; Morgan, L | 1 |
Beck, B; Blum, J; Funk, M; Furrer, H; Genton, B; Hatz, FR; Holzer, B; Loutan, L; Markwalder, K; Raeber, PA; Schlagenhauf, P; Siegl, G; Steffen, R; Stürchler, D; Wyss, R | 1 |
Behrens, RH; Bienzle, U; Chulay, JD; Clarke, PD; Kain, KC; Knobloch, J; Nothdurft, HD; Overbosch, D; Roskell, NS; Schilthuis, H; Shaw, D; Toovey, S | 1 |
Davies, CS; Matthews, PJ; Pudney, M; Sinden, RE | 1 |
Gutteridge, WE | 1 |
28 review(s) available for atovaquone and Malaria
Article | Year |
---|---|
Targeting the liver stage of malaria parasites: a yet unmet goal.
Topics: Animals; Antimalarials; Humans; Life Cycle Stages; Liver; Malaria; Plasmodium; Structure-Activity Relationship | 2012 |
Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action.
Topics: Antimalarials; Biological Products; Chemistry, Pharmaceutical; Humans; Malaria; Molecular Structure | 2016 |
Current progress in antimalarial pharmacotherapy and multi-target drug discovery.
Topics: Animals; Antimalarials; Artemisinins; Drug Discovery; Drug Resistance; Humans; Malaria; Molecular Structure; Paclitaxel; Quinolines | 2020 |
Recognition and Management of Malaria.
Topics: Antimalarials; Atovaquone; Drug Combinations; Ghana; Humans; Malaria; Male; Middle Aged; Practice Guidelines as Topic; Proguanil; Risk Factors; Severity of Illness Index; Travel-Related Illness; Treatment Outcome; United States | 2019 |
The genomic architecture of antimalarial drug resistance.
Topics: Aminoquinolines; Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Drug Resistance; Drug Resistance, Multiple; Folic Acid Antagonists; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Quinine | 2019 |
Expanded table: drugs for prophylaxis of malaria.
Topics: Aminoquinolines; Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Pre-Exposure Prophylaxis; Statistics as Topic; Travel | 2019 |
Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
Topics: Animals; Antimalarials; Atovaquone; Chemoprevention; Disease Outbreaks; Dogs; Drug Combinations; Humans; Malaria; Mice; Models, Animal; Plasmodium falciparum; Plasmodium malariae; Proguanil; Rats; Travel | 1999 |
Clinical pharmacology of atovaquone and proguanil hydrochloride.
Topics: Animals; Antimalarials; Atovaquone; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Activation; Humans; Intestinal Absorption; Intestinal Mucosa; Lymphocytes; Malaria; Malaria, Falciparum; Malaria, Vivax; Proguanil | 1999 |
Is the Mitochondrion a Good Malaria Drug Target?
Topics: Antimalarials; Atovaquone; Drug Delivery Systems; Drug Resistance; Humans; Malaria; Mitochondria; Plasmodium falciparum | 2017 |
Antimalarial drugs: modes of action and mechanisms of parasite resistance.
Topics: Antimalarials; Artemisinins; Atovaquone; Drug Resistance; Folic Acid Antagonists; Humans; Malaria; Plasmodium falciparum; Quinolines | 2010 |
Pharmacokinetics of antimalarials in pregnancy: a systematic review.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2011 |
Review: Malaria chemoprophylaxis for travelers to Latin America.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Humans; Latin America; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Proguanil; Travel | 2011 |
Antimalarial pharmacology and therapeutics of atovaquone.
Topics: Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Humans; Malaria; Proguanil; United States | 2013 |
Current drugs for antimalarial chemoprophylaxis: a review of efficacy and safety.
Topics: Antimalarials; Atovaquone; Chloroquine; Doxycycline; Humans; Malaria; Mefloquine; Naphthoquinones; Primaquine; Proguanil | 2001 |
[Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil].
Topics: Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Approval; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Naphthoquinones; Netherlands; Proguanil; Sesquiterpenes; Treatment Outcome | 2003 |
Atovaquone/proguanil: the need for family protection.
Topics: Adult; Africa South of the Sahara; Aged; Antimalarials; Atovaquone; Child; Drug Combinations; Drug Resistance; Family; Humans; Malaria; Naphthoquinones; New Guinea; Proguanil; Randomized Controlled Trials as Topic; Travel; United States | 2003 |
New antimalarial drugs.
Topics: Aminoquinolines; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Design; Drug Resistance; Ethanolamines; Flavonoids; Fluorenes; Fosfomycin; Global Health; Humans; Lumefantrine; Malaria; Naphthoquinones; Naphthyridines; Plasmodium falciparum; Proguanil; Sesquiterpenes | 2003 |
Military aviators, special operations forces, and causal malaria prophylaxis.
Topics: Aminoquinolines; Antimalarials; Atovaquone; Aviation; Chloroquine; Doxycycline; Drug Combinations; Humans; Malaria; Mefloquine; Military Personnel; Naphthoquinones; Primaquine; Proguanil; United States | 2003 |
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel | 2004 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel | 2003 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel | 2004 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Chloroquine; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Travel | 2004 |
Malaria: prevention in travellers.
Topics: Adult; Antimalarials; Atovaquone; Child; Clothing; Doxycycline; Female; Humans; Insect Repellents; Insecticides; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Pregnancy; Proguanil; Travel | 2005 |
[New drugs against parasitic diseases].
Topics: Antimalarials; Atovaquone; Humans; Malaria; Parasitic Diseases | 2007 |
Drug-resistant malaria - an insight.
Topics: Animals; Antimalarials; Artemisinins; Atovaquone; Chloroquine; Drug Resistance; Folic Acid Antagonists; Humans; Malaria | 2007 |
A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Proguanil | 2007 |
[Malaria--chemoprophylaxis 2001].
Topics: Africa; Antimalarials; Asia; Atovaquone; Chloroquine; Contraindications; Doxycycline; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Practice Guidelines as Topic; Proguanil; South America; Switzerland; Travel | 2001 |
Antimalarial drugs currently in development.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Atovaquone; Chemical Phenomena; Chemistry; Drug Design; Drug Evaluation, Preclinical; Drug Resistance; Humans; Malaria; Naphthoquinones; Research; Sesquiterpenes | 1989 |
10 trial(s) available for atovaquone and Malaria
Article | Year |
---|---|
Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.
Topics: Amodiaquine; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Proguanil; Treatment Outcome | 2022 |
Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
Topics: Adult; Aged; Aged, 80 and over; Antimalarials; Atovaquone; Australia; Chemoprevention; Drug Administration Schedule; Drug Combinations; Drug Tolerance; Female; Holidays; Humans; Malaria; Male; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Proguanil; Surveys and Questionnaires; Travel; Travel Medicine; Young Adult | 2019 |
A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Atovaquone; Azithromycin; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Endpoint Determination; Female; Genotyping Techniques; Humans; Infant; Longitudinal Studies; Malaria; Male; Proguanil | 2012 |
Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events.
Topics: Adolescent; Adult; Affect; Antimalarials; Atovaquone; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Naphthoquinones; Proguanil; Prospective Studies; Sex Factors | 2002 |
Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.
Topics: Administration, Oral; Adolescent; Antimalarials; Atovaquone; Chemoprevention; Child; Child, Preschool; Cholera Vaccines; Double-Blind Method; Female; Humans; Immunity; Malaria; Male; Naphthoquinones; Proguanil; Treatment Outcome; Typhoid-Paratyphoid Vaccines | 2002 |
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Topics: Adolescent; Antimalarials; Atovaquone; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Humans; Infant; Malaria; Naphthoquinones; Patient Compliance; Proguanil; Travel | 2004 |
Randomized, double-blind, placebo-controlled study of Malarone for malaria prophylaxis in non-immune Colombian soldiers.
Topics: Adolescent; Adult; Antimalarials; Atovaquone; Colombia; Double-Blind Method; Drug Combinations; Humans; Malaria; Male; Military Personnel; Naphthoquinones; Placebos; Proguanil | 2006 |
Atovaquone and proguanil for the treatment of malaria in Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Brazil; Drug Therapy, Combination; Humans; Malaria; Male; Middle Aged; Naphthoquinones; Proguanil; Quinine; Tetracycline | 1997 |
Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
Topics: Adolescent; Antimalarials; Atovaquone; Child; Child, Preschool; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; Humans; Malaria; Naphthoquinones; Proguanil | 1998 |
Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Naphthoquinones; Proguanil; Travel; Treatment Outcome | 2001 |
109 other study(ies) available for atovaquone and Malaria
Article | Year |
---|---|
Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore.
Topics: Acrylates; Administration, Cutaneous; Administration, Oral; Animals; Antimalarials; Benzene Derivatives; Erythrocytes; In Vitro Techniques; Malaria; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2000 |
Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
Topics: Animals; Antimalarials; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium falciparum; Plasmodium yoelii; Pyridones; Structure-Activity Relationship | 2008 |
Spiroindolones, a potent compound class for the treatment of malaria.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Cell Line; Drug Discovery; Drug Resistance; Erythrocytes; Female; Genes, Protozoan; Humans; Indoles; Malaria; Male; Mice; Models, Molecular; Mutant Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Synthesis Inhibitors; Protozoan Proteins; Rats; Rats, Wistar; Spiro Compounds | 2010 |
Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.
Topics: Animals; Antimalarials; Dihydroorotate Dehydrogenase; Disease Models, Animal; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Malaria; Mice; Microsomes, Liver; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Pyrimidines; Solubility; Structure-Activity Relationship; Triazoles | 2011 |
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Topics: Administration, Oral; Animals; Antimalarials; Crystallography, X-Ray; Drug Design; Electron Transport Complex III; Humans; In Vitro Techniques; Malaria; Male; Mice; Microsomes, Liver; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolones; Quinone Reductases; Structure-Activity Relationship | 2012 |
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Crystallography, X-Ray; Cytochromes b; Drug Design; Drug Resistance; Humans; Malaria; Male; Mice; Microsomes, Liver; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyridines; Quinolones; Quinone Reductases; Rats; Structure-Activity Relationship | 2012 |
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
Topics: Antimalarials; Cell Line, Tumor; Humans; Imines; Liver; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2013 |
Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials.
Topics: Animals; Antimalarials; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Malaria; Mice, Inbred C57BL; Molecular Docking Simulation; Nitriles; Oxidative Stress; Peptidomimetics; Plasmodium berghei; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Tetraoxanes | 2014 |
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.
Topics: Aminopyridines; Animals; Antimalarials; Benzimidazoles; Hepatocytes; Humans; Malaria; Mice, SCID; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2014 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.
Topics: Animals; Antimalarials; High-Throughput Screening Assays; Humans; In Vitro Techniques; Malaria; Malaria, Falciparum; Mice; Mice, SCID; Microsomes, Liver; Plasmodium berghei; Plasmodium falciparum; Serine Proteinase Inhibitors; Structure-Activity Relationship; Triazoles | 2015 |
Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.
Topics: Antimalarials; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Indoles; Malaria; Molecular Structure; Niacinamide; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2015 |
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model.
Topics: Animals; Antimalarials; Benzimidazoles; Life Cycle Stages; Malaria; Male; Mice; Plasmodium berghei; Structure-Activity Relationship | 2017 |
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
Topics: Amides; Animals; Antimalarials; Boron Compounds; Dogs; Female; Humans; Malaria; Malaria, Falciparum; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2017 |
3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.
Topics: Amides; Animals; Antimalarials; Hep G2 Cells; Humans; Hydrazones; Malaria; Mice; Phenanthrenes; Plasmodium berghei; Stereoisomerism; Structure-Activity Relationship | 2017 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship | 2021 |
Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
Topics: Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Blood-Borne Pathogens; Diminazene; Humans; Imidocarb; Malaria; Plants, Medicinal | 2021 |
Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Female; Malaria; Malaria, Falciparum; Plasmodium; Plasmodium falciparum | 2022 |
Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients.
Topics: Antimalarials; Atovaquone; Case-Control Studies; Chemoprevention; Chloroquine; Humans; Malaria; Malaria, Vivax; Plasmodium ovale; Plasmodium vivax; Travel | 2023 |
Mitochondrially targeted proximity biotinylation and proteomic analysis in Plasmodium falciparum.
Topics: Antimalarials; Atovaquone; Biotinylation; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Proteomics | 2022 |
Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis.
Topics: Animals; Atovaquone; Babesia microti; Babesiosis; Clofazimine; Cysteine Proteases; Drug Repositioning; Imidocarb; Malaria; Mice; Theileria | 2022 |
Symptoms of illness during travel and risk factors for non-adherence to malaria prophylaxis-a cross-sectional study in travellers from Germany.
Topics: Adult; Antimalarials; Atovaquone; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Germany; Humans; Malaria; Prescriptions; Proguanil; Risk Factors; Travel; Travel-Related Illness | 2023 |
Topics: Animals; Atovaquone; DNA, Mitochondrial; Endodeoxyribonucleases; Humans; Malaria; Malaria, Falciparum; Parasites; Plasmodium falciparum; Protozoan Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2023 |
Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito.
Topics: Animals; Anopheles; Antimalarials; Antiparasitic Agents; Atovaquone; Humans; Malaria; Malaria, Falciparum; Mice; Parasites; Plasmodium falciparum; Vaccines | 2023 |
A case of acute generalized exanthematous pustulosis caused by exposure to Atovaquone/proguanil.
Topics: Acute Generalized Exanthematous Pustulosis; Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Proguanil | 2020 |
Deployment and Travel Medicine Knowledge, Attitudes, Practices, and Outcomes Study (KAPOS): Malaria Chemoprophylaxis Prescription Patterns in the Military Health System.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Military Medicine; Military Personnel; Practice Patterns, Physicians'; Primaquine; Proguanil; United States; Young Adult | 2020 |
Exploring Ubiquinone Biosynthesis Inhibition as a Strategy for Improving Atovaquone Efficacy in Malaria.
Topics: Atovaquone; Humans; Malaria; Mitochondria; Oxidation-Reduction; Ubiquinone | 2021 |
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia.
Topics: Adult; Artemisinins; Atovaquone; Cambodia; Coinfection; Drug Combinations; Drug Resistance, Multiple; Humans; Lactones; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Proguanil; Quinine; Travel; Treatment Outcome | 2017 |
Plasmodium knowlesi malaria in a traveller returning from the Philippines to Italy, 2016.
Topics: Antimalarials; Atovaquone; Diagnosis, Differential; Drug Combinations; Humans; Italy; Malaria; Philippines; Plasmodium knowlesi; Proguanil; Travel | 2017 |
Hemophagocytic lymphohistiocytosis with concurrent malarial infection.
Topics: Antimalarials; Atovaquone; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic; Malaria; Male; Prednisone; Proguanil; Young Adult | 2017 |
Acute malaria infection after atovaquone-proguanil prophylaxis.
Topics: Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Proguanil; Travel | 2017 |
Atovaquone oral bioavailability enhancement using electrospraying technology.
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Biological Availability; Drug Combinations; Malaria; Mice; Plasmodium berghei; Proguanil; Rats | 2018 |
Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Atovaquone; Chloroquine; Communicable Diseases, Imported; Drug Combinations; Emigrants and Immigrants; Humans; Infant; Liberia; Malaria; Male; Plasmodium malariae; Proguanil; Recurrence; Treatment Outcome; United States | 2018 |
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Chemoprevention; Disease Models, Animal; Drug Carriers; Drug Resistance; Female; Humans; Malaria; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Plasmodium berghei; Theranostic Nanomedicine | 2018 |
Abnormal Ophthalmic Examination Results and Elevated Intracranial Pressure.
Topics: Adult; Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Humans; Intracranial Hypertension; Intracranial Pressure; Malaria; Male; Papilledema; Physical Examination; Proguanil; Visual Acuity; Withholding Treatment | 2018 |
Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
Topics: Adult; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Diagnostic Errors; Drug Combinations; Equatorial Guinea; Female; Humans; Malaria; Primaquine; Proguanil; Spain; Travel | 2018 |
Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine.
Topics: Aminoquinolines; Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Proguanil; Travel | 2019 |
Safety of atovaquone-proguanil during pregnancy.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Premature Birth; Proguanil; Travel; Young Adult | 2019 |
Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa.
Topics: Adult; Africa South of the Sahara; Aged; Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Middle Aged; Proguanil; Travel; Young Adult | 2019 |
[Descriptive study of malaria cases in the paediatric population in a reference hospital in Valencia, Spain, between 1993 and 2015].
Topics: Adolescent; Age Distribution; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Child, Preschool; Drug Combinations; Equatorial Guinea; Female; Hospitals, Community; Humans; Infant; Malaria; Male; Proguanil; Quinine; Quinolines; Retrospective Studies; Sex Distribution; Spain; Symptom Assessment | 2020 |
Diagnosis of malaria in a traveler 9 months after returning from West Africa by
Topics: Africa, Western; Antimalarials; Atovaquone; Drug Combinations; Germany; Humans; Malaria; Male; Middle Aged; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Plasmodium ovale; Primaquine; Proguanil; Sensitivity and Specificity; Travel-Related Illness | 2019 |
Quinolone-3-diarylethers: a new class of antimalarial drug.
Topics: Animals; Antimalarials; Atovaquone; Drug Resistance; Drug Synergism; Life Cycle Stages; Malaria; Malaria, Falciparum; Mice; Plasmodium falciparum; Plasmodium vivax; Proguanil; Pyridones; Quinolones | 2013 |
Prophylactic drugs for malaria: why do we need another one?
Topics: Adult; Antimalarials; Atovaquone; Chemoprevention; Child; Chloroquine; Developed Countries; Developing Countries; Drug Combinations; Female; Guidelines as Topic; Humans; Malaria; Male; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Risk Factors; Travel; Travel Medicine; Young Adult | 1999 |
Malarone Donation Program.
Topics: Africa, Eastern; Antimalarials; Atovaquone; Developing Countries; Drug Combinations; Drug Industry; Humans; Internationality; Malaria; Medical Indigency; Proguanil; World Health Organization | 1999 |
Transmission-blocking interventions eliminate malaria from laboratory populations.
Topics: Animals; Animals, Laboratory; Anopheles; Antimalarials; Atovaquone; Feeding Behavior; Female; Geography; Malaria; Mice; Models, Biological; Plasmodium berghei | 2013 |
Use of qPCR and genomic sequencing to diagnose Plasmodium ovale wallikeri malaria in a returned soldier in the setting of a negative rapid diagnostic assay.
Topics: Adult; Atovaquone; Base Sequence; DNA, Protozoan; Genome, Protozoan; Humans; Liberia; Malaria; Male; Military Personnel; Molecular Sequence Data; Plasmodium ovale; Proguanil; Real-Time Polymerase Chain Reaction; Sequence Alignment | 2013 |
Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria.
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Diffusion; Drug Compounding; Emulsions; Malaria; Male; Metabolic Clearance Rate; Mice; Nanocapsules; Particle Size; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2014 |
Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand.
Topics: Antimalarials; Atovaquone; Coinfection; Drug Combinations; Germany; HIV Infections; Humans; Malaria; Male; Middle Aged; Plasmodium knowlesi; Proguanil; Thailand; Travel; Viral Load | 2013 |
[Malaria].
Topics: Antimalarials; Artemisinins; Artesunate; Atovaquone; Drug Therapy, Combination; Humans; Malaria; Prevalence; Proguanil | 2014 |
Phototoxic reaction associated with Malarone (atovaquone/proguanil) antimalarial prophylaxis.
Topics: Adult; Antimalarials; Atovaquone; Dermatitis, Phototoxic; Drug Combinations; Humans; Malaria; Male; Proguanil; Travel | 2014 |
Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
Topics: Aminoquinolines; Animals; Antimalarials; Atovaquone; Disease Models, Animal; Drug Combinations; Macaca mulatta; Malaria; Parasitemia; Plasmodium cynomolgi; Primaquine; Proguanil | 2014 |
Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.
Topics: Africa; Antimalarials; Atovaquone; Chemoprevention; Doxycycline; Drug Combinations; Health Knowledge, Attitudes, Practice; Humans; Malaria; Medication Adherence; Mefloquine; Peace Corps; Proguanil; Travel; United States; Volunteers | 2014 |
Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.
Topics: Amides; Animals; Antimalarials; Atovaquone; Biological Products; Cell Line; Chemistry Techniques, Synthetic; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Malaria; Male; Mice; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship; Triazines; Urea | 2015 |
Assessment of real-time method to detect liver parasite burden under different experimental conditions in mice infected with Plasmodium yoelii sporozoites.
Topics: Animals; Antimalarials; Atovaquone; Liver; Malaria; Mice; Parasite Load; Plasmodium yoelii; Primaquine; Real-Time Polymerase Chain Reaction; Sporozoites; Treatment Outcome | 2015 |
Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
Topics: Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Cell Nucleus; Cytochromes b; Drug Resistance; Gene Expression; Host-Parasite Interactions; Malaria; Mice; Mice, Inbred BALB C; Mitochondria; Mutation Rate; Parasitic Sensitivity Tests; Plasmodium berghei; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2016 |
Bioavailability enhancement of atovaquone using hot melt extrusion technology.
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Biological Availability; Drug Combinations; Drug Liberation; Hot Temperature; Malaria; Male; Mice; Plasmodium berghei; Proguanil; Rats, Sprague-Dawley; Solubility; Technology, Pharmaceutical | 2016 |
Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Cell Line; Cytochromes b; Drug Resistance; Genes, Mitochondrial; Humans; Life Cycle Stages; Malaria; Male; Mice; Mitochondria; Mutation; Plasmodium berghei; Selection, Genetic | 2016 |
Malaria in British military personnel deployed to Sierra Leone: a case series.
Topics: Antimalarials; Atovaquone; Cohort Studies; Doxycycline; Drug Combinations; Humans; Malaria; Mefloquine; Military Personnel; Proguanil; Sierra Leone; Treatment Outcome; United Kingdom | 2017 |
Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
Topics: Africa South of the Sahara; Africa, Western; Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Humans; Malaria; Proguanil; Travel | 2016 |
The conundrum of malaria chemoprophylaxis.
Topics: Antimalarials; Atovaquone; Chemoprevention; Drug Therapy, Combination; Humans; Malaria; Proguanil; Travel | 2016 |
Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations.
Topics: Animals; Antimalarials; Atovaquone; Cytochromes b; Drug Dosage Calculations; Drug Resistance; Malaria; Medication Errors; Mice; Mice, Inbred BALB C; Plasmodium berghei | 2017 |
Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Artemisinins; Atovaquone; Child; Clinical Trials as Topic; Drug Approval; Drug Therapy, Combination; Ethanolamines; Europe; Fluorenes; Humans; Malaria; Plasmodium falciparum; Proguanil | 2008 |
Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
Topics: Animals; Antimalarials; Atovaquone; Chemoprevention; Female; Humans; Liberia; Malaria; Male; Mefloquine; Military Medicine; Military Personnel; Plasmodium falciparum; Proguanil; Retrospective Studies; Surveys and Questionnaires; Sweden | 2008 |
Atovaquone + proguanil: new indication. For children weighing as little as 5 kg; an inconvenient form. A flavoured syrup would be better suited to infants and young children.
Topics: Administration, Oral; Antimalarials; Atovaquone; Body Weight; Chemistry, Pharmaceutical; Child; Child, Preschool; Dosage Forms; Drug Administration Schedule; Drug Approval; Drug Combinations; France; Humans; Infant; Malaria; Malaria, Falciparum; Proguanil; Tablets | 2009 |
Probing binding determinants in center P of the cytochrome bc(1) complex using novel hydroxy-naphthoquinones.
Topics: Animals; Antimalarials; Atovaquone; Cattle; Cytochromes b; Electron Transport Complex III; Humans; Kinetics; Malaria; Naphthoquinones; Plasmodium falciparum; Pneumocystis | 2010 |
Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Topics: Animals; Antimalarials; Atovaquone; Cytochromes b; DNA, Protozoan; Drug Resistance; Female; Genotype; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium chabaudi; Point Mutation | 2010 |
Community management of anti-malarials in Africa and iatrogenic risk.
Topics: Antimalarials; Atovaquone; Child; Community Health Services; Contraindications; Cote d'Ivoire; Diagnostic Errors; Drug Combinations; Female; Humans; Iatrogenic Disease; Liver Failure, Acute; Malaria; Proguanil; Pyrimethamine; Sulfadoxine | 2011 |
Atovaquone-proguanil use in early pregnancy and the risk of birth defects.
Topics: Abnormalities, Drug-Induced; Antimalarials; Atovaquone; Cohort Studies; Cross-Sectional Studies; Denmark; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Product Surveillance, Postmarketing; Proguanil; Registries | 2011 |
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.
Topics: Adult; Anti-HIV Agents; Antimalarials; Atovaquone; Chemoprevention; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Malaria; Nitriles; Plasma; Proguanil; Pyridazines; Pyrimidines; Saquinavir | 2011 |
Prophylactic use of antimalarials during pregnancy.
Topics: Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Doxycycline; Drug Combinations; Female; Humans; Hydroxychloroquine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Proguanil; Travel | 2011 |
Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug.
Topics: Animals; Antimalarials; Atovaquone; Cell Line, Tumor; Decoquinate; Drug Evaluation, Preclinical; Hepatocytes; Humans; Malaria; Mitochondria; Models, Molecular; Molecular Structure; Plasmodium; Protein Conformation | 2012 |
Anti-malarial chemoprophylaxis following evacuation from Afghanistan.
Topics: Afghan Campaign 2001-; Antimalarials; Atovaquone; Chemoprevention; Chloroquine; Clinical Audit; Doxycycline; Drug Combinations; Drug Prescriptions; Humans; Malaria; Mefloquine; Military Personnel; Proguanil | 2012 |
Standby emergency treatment of malaria in travelers: experience to date and new developments.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Chloroquine; Diagnostic Tests, Routine; Drug Combinations; Emergency Treatment; Ethanolamines; Female; Fluorenes; Geography; Guidelines as Topic; Health Policy; Humans; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Sensitivity and Specificity; Travel; Travel Medicine | 2012 |
Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy; Ethanolamines; Europe; Female; Fluorenes; Humans; Malaria; Male; Mefloquine; Middle Aged; Proguanil; Prospective Studies; Young Adult | 2012 |
Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Chemoprevention; Child; Drug Combinations; Female; Humans; Japan; Malaria; Male; Mefloquine; Middle Aged; Proguanil; Surveys and Questionnaires; Travel; Young Adult | 2013 |
Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon.
Topics: Adult; Antigens, Protozoan; Atovaquone; Cameroon; Child, Preschool; Drug Combinations; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Likelihood Functions; Malaria; Parasite Load; Parasitemia; Plasmodium; Predictive Value of Tests; Proguanil; Protozoan Proteins; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2013 |
Relapsing malaria: two cases of malaria presenting 8 months after return from Africa despite adherence to antimalarial chemoprophylaxis.
Topics: Adolescent; Africa; Antimalarials; Atovaquone; Delayed Diagnosis; Drug Combinations; Humans; Malaria; Male; Medication Adherence; Plasmodium ovale; Proguanil; Recurrence; Travel; United Kingdom | 2012 |
[Preventive vaccination for travel. Every dog has it, but only every 10th grandmother].
Topics: Adult; Aged; Animals; Antimalarials; Atovaquone; Child; Dogs; Drug Combinations; Germany; Humans; Malaria; Naphthoquinones; Proguanil; Travel; Tropical Medicine; Vaccination | 2002 |
The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
Topics: Adult; Antimalarials; Atovaquone; Denmark; Drug Administration Schedule; Drug Combinations; Eritrea; Humans; Malaria; Male; Military Personnel; Naphthoquinones; Proguanil; Surveys and Questionnaires; Travel | 2003 |
Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
Topics: Antimalarials; Atovaquone; Drug Combinations; Endemic Diseases; Europe; Female; Humans; Longitudinal Studies; Malaria; Male; Naphthoquinones; Product Surveillance, Postmarketing; Proguanil; Prospective Studies; Surveys and Questionnaires; Travel | 2003 |
Malaria and children: the risks, precautions, and the nurse's role.
Topics: Animals; Antimalarials; Atovaquone; Chemoprevention; Child; Culicidae; Doxycycline; Drug Combinations; Humans; Insect Bites and Stings; Malaria; Mefloquine; Naphthoquinones; Proguanil; Travel | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
A malaria outbreak following a British military deployment to Sierra Leone.
Topics: Antimalarials; Atovaquone; Disease Outbreaks; Doxycycline; Drug Combinations; Humans; Malaria; Male; Mefloquine; Military Personnel; Naphthoquinones; Proguanil; Sierra Leone | 2004 |
A malaria outbreak following a British military deployment to Sierra Leone.
Topics: Antimalarials; Atovaquone; Chemoprevention; Disease Outbreaks; Doxycycline; Drug Combinations; Humans; Malaria; Male; Mefloquine; Military Personnel; Naphthoquinones; Proguanil; Sierra Leone; United Kingdom | 2005 |
Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae.
Topics: Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Cytochromes b; Dose-Response Relationship, Drug; Electron Transport Complex III; Inhibitory Concentration 50; Kinetics; Malaria; Models, Molecular; Molecular Sequence Data; Mutation; Naphthoquinones; Oxygen Consumption; Plasmodium falciparum; Point Mutation; Protein Binding; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Time Factors; Ubiquinone | 2005 |
Effectiveness of antimalarial drugs.
Topics: Antimalarials; Atovaquone; Drug Combinations; Humans; Malaria; Mefloquine; Naphthoquinones; Proguanil | 2005 |
[Malaria prophylaxis for long-term travellers and expatriates].
Topics: Antimalarials; Atovaquone; Chloroquine; Counseling; Doxycycline; Drug Combinations; Humans; Insect Bites and Stings; Malaria; Mefloquine; Mosquito Control; Naphthoquinones; Proguanil; Risk Assessment; Risk Factors; Travel | 2005 |
[Ineffective change of antimalaria prophylaxis to Artemisia vulgaris in a group travelling to West Africa].
Topics: Africa, Western; Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Naphthoquinones; Plant Preparations; Proguanil; Surveys and Questionnaires; Travel | 2005 |
Plasmodium falciparum malaria associated with mefloquine failure in Gambia.
Topics: Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Gambia; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Proguanil; Risk Assessment; Risk Factors; Travel; Treatment Failure; United States | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Inadequate chemoprophylaxis and the risk of malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Australia; Chemoprevention; Doxycycline; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Papua New Guinea; Proguanil; Retrospective Studies; Risk Factors | 2007 |
Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
Topics: Adolescent; Adult; Antimalarials; Atovaquone; Consumer Health Information; Decision Making; Doxycycline; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Proguanil; Prospective Studies; Switzerland; Time Factors; Travel | 2007 |
Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
Topics: Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Benzoquinones; Cytochrome b Group; Drug Resistance; Malaria; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei | 2008 |
Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
Topics: Acridines; Animals; Antimalarials; Atovaquone; Cattle; Drug Synergism; Electron Transport Complex III; Heme; Hemeproteins; Humans; Malaria; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxidation-Reduction; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Rats, Wistar; Saccharomyces cerevisiae | 2008 |
Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
Topics: Aged; Animals; Antimalarials; Atovaquone; Cameroon; Diagnosis, Differential; Fever; France; Headache; Humans; Malaria; Male; Plasmodium ovale; Proguanil; Travel | 2008 |
Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
Topics: Amides; Animals; Antimalarials; Atovaquone; Bicarbonates; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dihydroorotase; Dihydroorotate Dehydrogenase; Erythrocytes; Humans; Kinetics; Malaria; Naphthoquinones; Orotic Acid; Orotidine-5'-Phosphate Decarboxylase; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium falciparum; Pyrazoles; Pyrimidines; Ribonucleosides; Ribose | 1994 |
Inhibitory action of the anti-malarial compound atovaquone (566C80) against Plasmodium berghei ANKA in the mosquito, Anopheles stephensi.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Enzyme-Linked Immunosorbent Assay; Female; Insect Vectors; Malaria; Mice; Naphthoquinones; Plasmodium berghei; Protozoan Proteins | 1994 |
Malarone-donation programme in Africa.
Topics: Africa; Altruism; Antimalarials; Atovaquone; Developing Countries; Drug Combinations; Drug Industry; Humans; Malaria; Naphthoquinones; Proguanil | 1997 |
Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Risk Assessment | 1998 |
Malaria prophylaxis for the 1990s and beyond.
Topics: Antimalarials; Atovaquone; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Proguanil | 1997 |
Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
Topics: Animals; Antimalarials; Atovaquone; Chromatography, High Pressure Liquid; Culicidae; Disease Vectors; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Mice; Naphthoquinones; Plasmodium berghei; Proguanil; Rats; Rats, Wistar | 2000 |
Atovaquone and proguanil hydrochloride.
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Drug Interactions; Humans; Malaria; Naphthoquinones; Proguanil | 2000 |
Efficacy of atovaquone-proguanil?
Topics: Antimalarials; Atovaquone; Doxycycline; Drug Combinations; Humans; Malaria; Naphthoquinones; Proguanil; Travel | 2001 |
[Expanded arsenal for prevention and therapy. What is the value of the new malaria drugs? (interview by Waltraut Paukstadt)].
Topics: Antimalarials; Atovaquone; Drug Administration Schedule; Drug Combinations; Humans; Malaria; Mefloquine; Naphthoquinones; Proguanil; Treatment Outcome | 2001 |
The causal prophylactic activity of the novel hydroxynaphthoquinone 566C80 against Plasmodium berghei infections in rats.
Topics: Animals; Antimalarials; Atovaquone; Drug Evaluation, Preclinical; Erythrocytes; Female; Malaria; Naphthoquinones; Plasmodium berghei; Rats; Rats, Inbred BN | 1989 |